THESIS · LIVE /T·184 / CLST /FILED 22 APR 2026 · 06:14 ET
CLST.N 148.20 +1.84% /POSITION MTD +9.8%
Eschatos Research
EST. MMXXIV · ISSUE 184
Search ticker, exec, filing…⌘K
CLST.N LONG · CORE Coverage initiated 2024 · Re-rated Q1 2026

Coalstone is being repriced as a specialty input, not a building material — and the market hasn't caught the sentence.

A re-rating thesis built on eleven plant visits, four buyer interviews, three quarters of transcript reads, and a dossier on the operator now running CLST. Long, conviction high, horizon 18–24 months.

DH
D. Halberd
Lead Analyst · Industrials
5,400 words · 22 min read · 34 citations

§ 01The sentence the market hasn't read

Coalstone is still modeled by the Street as a regional cyclical building material. It is not. Across 11 plant visits and 4 direct conversations with battery-housing OEM procurement leads, the operating posture inside CLST is now that of a specialty input supplier with one cyclical legacy line. EV-04421↗

The pivot is not announced. It is observable. The capex line previously labeled "maintenance" in the Q3 2025 10-Q is reclassified in Q1 2026 as "specialty conversion." EV-04421↗ The CFO uses the phrase "specialty mix" five times on the Q1 call. The phrase did not appear once in any of the prior eight transcripts. EV-04420↗

"You build the product first, narrate it second, and the multiple comes third. Coalstone is somewhere between step one and step two."

§ 02What we did to verify

  • Walked or photographed 11 of 14 active plants between September 2025 and March 2026.
  • Interviewed procurement leads at 4 battery-housing OEMs; two on the record.
  • Reconciled 3 beneficial-ownership disclosures against the proxy.
  • Cross-checked shipping manifest data for two ports against reported segment volume.
  • Built a peer screen of 14 NA specialty cement and adjacents in Adamas Terminal.

§ 03The numbers

Entry$112.4022 Jan 2026
Last$148.2025 Apr 2026
PT · 24m$210+41.7% from last

We model specialty mix at 22% of revenue by 2027 versus 8% consensus. The path is not subtle: capex resequencing implies 3 additional plants converted by Q2 2027, and the specialty multiple — even haircut to 14× — re-rates the consolidated group meaningfully. EV-04419↗

§ 04What we are watching

  • Plant 7 conversion timeline. Slips beyond Q3 2026 and the model softens.
  • R. Mendel's transcript language. We escalate the dossier if "specialty" appearances reverse. EX-2241↗
  • Two open governance items on the case file: capex disclosure breadth and segment reporting granularity. CF-CLST-09↗

§ 05What would force us off

A reversal of the capex reclassification, a CFO change, or a single quarter where specialty volume disappoints by more than 15% against our internal track. We will say so in writing and the row will sit in the ledger.

Disclosures
Eschatos and affiliated entities hold a long position in CLST.N as of filing. No relationship with management. No payment received. Position changes are logged to the dossier within 24 hours.